Irish Examiner on MSN11h
On the rebound: What are the long-term risks of Ozempic?
Ahead of World Obesity Day, we examine the impact of the game-changing drugs that control appetite. Increasingly being taken ...
The American Journal of Managed Care18h
Medicare Part D Spending Trends for Type 2 Diabetes Medications
New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...
JD Supra17h
FDA Announces End to Semaglutide Shortage, Impacting Compounders and Telehealth Providers Offering Injectable GLP-1 Drugs
Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...
protothema.gr22h
Denmark has appealed to the… Ozempic CEO on how to manage Trump wanting Greenland
Lars Fruergaard Jørgensen is a CEO who didn't want to be CEO but under his tenure Novo Nordisk, which makes Ozempic, has ...
telecareaware.com15h
These just in: drug compounders sue FDA over semaglutide scarcity removal; Sycamore’s Walgreens buy plans begin to show
What the telehealth prescribers can’t do, the compounders are. A major drug compounder association, the Outsourcing Facilities Association, along with member North American Custom Laboratories, LLC, ...